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INTRODUCTION
Over the last two decades, a worldwide rise in obesity has resulted
in 1.46 billion overweight [body mass index (BMI)>25] and 502
million obese (BMI>30) adults (Finucane et al., 2011). Obesity is a
public health problem of the first order for industrialized nations,
potentially even leading to a decrease in overall life expectancy
(Olshansky et al., 2005). Co-morbidities for obesity include diabetes
mellitus type 2, cardiovascular disease, hepatic steatosis, Alzheimer’s
disease, chronic kidney disease and certain cancers (Haslam and
James, 2005; Brunt, 2010; Barnes and Yaffe, 2011). Notably, in their
2009 policy report entitled ‘Policy and Action for Cancer Prevention’,
the World Cancer Research Fund/American Institute for Cancer
Research (WCRF/AICR) states that 20% of all kidney cancer cases
in males and 28% in females could be avoided by maintaining an
appropriate body weight (http://www.dietandcancerreport.org/).
Nevertheless, the mechanisms underlying obesity-associated kidney
cancer remain largely unknown.
A major determinant for many obesity-induced sequelae is the
low-grade inflammation of the enlarged adipose tissue, and the
persistent release of inflammatory adipocytokines such as tumor
necrosis factor- (TNF) and interleukin-6 (IL-6) (Gregor and
Hotamisligil, 2011), which can adversely affect various non-adipose
target tissues. Such obesity-induced hepatic inflammation was
recently shown to promote tumor formation in livers of dietary
obese mice (Park et al., 2010). Indeed, the pro-tumorigenic role of
inflammatory cytokines, such as TNF and IL-6, is well established
(Yu et al., 2009; Grivennikov et al., 2010; Grivennikov and Karin,
2011; Kuraishy et al., 2011). Similarly, the majority of renal cell
carcinomas have been shown to express IL-6, and the presence of
IL-6 receptor was strongly associated with the tumor stage in kidney
cancer patients (Costes et al., 1997). Thus, inhibition of the IL-6
target signal transducer and activator of transcription 3 (STAT3)
is currently under investigation as a potential target for kidney
cancer therapy (Xin et al., 2009; Horiguchi et al., 2010).
We hypothesized that diet-induced obesity (DIO) promotes the
earliest stages of renal carcinogenesis via STAT3 activation. Using
chow-fed lean rats and two groups of high-fat diet (HFD)-fed rats
with either pronounced sensitivity to develop DIO (DIOsens rats)
or partial resistance to DIO (DIOres rats), we demonstrated a
correlation between body adiposity and the severity of kidney
pathology: DIOsens and DIOres rats (collectively referred to as DIO
rats) had increased renal inflammation and cytokine expression,
and higher incidences of nephropathies and preneoplastic lesions.
Notably, in tubules that had a preneoplastic phenotype, we observed
Disease Models & Mechanisms 627
Disease Models & Mechanisms 5, 627-635 (2012) doi:10.1242/dmm.009407
1Department of Internal Medicine, Metabolic Diseases Institute, University of
Cincinnati, Division of Endocrinology and Metabolism, 2170 East Galbraith Road,
Building E, Cincinnati, OH 45237, USA
2Institute for Diabetes and Obesity, Helmholtz Centre Munich, Ingolstädter
Landstrasse 1, D-85764 Neuherberg, Germany
3Human and Environmental Toxicology, Department of Biology, University of
Konstanz, Jacob-Burckhardt-Strasse 25, 78457 Konstanz, Germany
*Author for correspondence (kerstin.stemmer@helmholtz-muenchen.de)
Received 11 December 2011; Accepted 17 February 2012
© 2012. Published by The Company of Biologists Ltd
This is an Open Access article distributed under the terms of the Creative Commons Attribution
Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0), which
permits unrestricted non-commercial use, distribution and reproduction in any medium provided
that the original work is properly cited and all further distributions of the work or adaptation are
subject to the same Creative Commons License terms.
SUMMARY
Obesity and concomitant comorbidities have emerged as public health problems of the first order. For instance, obese individuals have an increased
risk for kidney cancer. However, direct mechanisms linking obesity with kidney cancer remain elusive. We hypothesized that diet-induced obesity
(DIO) promotes renal carcinogenesis by inducing an inflammatory and tumor-promoting microenvironment. We compared chow-fed lean Wistar
rats with those that were sensitive (DIOsens) or partially resistant (DIOres) to DIO to investigate the impact of body adiposity versus dietary nutrient
overload in the development of renal preneoplasia and activation of tumor-promoting signaling pathways. Our data clearly show a correlation
between body adiposity, the severity of nephropathy, and the total number and incidence of preneoplastic renal lesions. However, similar plasma
triglyceride, plasma free fatty acid and renal triglyceride levels were found in chow-fed, DIOres and DIOsens rats, suggesting that lipotoxicity is not
a critical contributor to the renal pathology. Obesity-related nephropathy was further associated with regenerative cell proliferation, monocyte
infiltration and higher renal expression of monocyte chemotactic protein-1 (MCP-1), interleukin (IL)-6, IL-6 receptor and leptin receptor. Accordingly,
we observed increased signal transducer and activator of transcription 3 (STAT3) and mammalian target of rapamycin (mTOR) phosphorylation in
tubules with preneoplastic phenotypes. In summary, our results demonstrate that high body adiposity induces an inflammatory and proliferative
microenvironment in rat kidneys that promotes the development of preneoplastic lesions, potentially via activation of the STAT3 and mTOR signaling
pathways.
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increased activation of STAT3 and mTOR signaling, two key
pathways that are involved in cell growth and survival by integrating
nutrient, hormonal and inflammatory signals (Dann et al., 2007;
Lee and Hung, 2007; Kuraishy et al., 2011); these pathways could
link DIO to renal carcinogenesis.
RESULTS
Differing propensity towards HFD-induced body weight gain
We first established a model of different susceptibility to HFD-
induced weight gain. Outbred Wistar rats with no previous
inbreeding and thus no genetic pre-selection for body weight
phenotypes were chronically exposed to either chow or a HFD for
a total of 11 months. Two phenotypes were selected from the HFD-
fed rats: high susceptibility to DIO (DIOsens) and partial resistance
to DIO (DIOres). These rats had a 122.95% and 38.78% increase
in body weight compared with chow-fed rats, respectively (Fig.
1A,B). DIOsens rats also demonstrated significantly higher visceral
(epididymal and retroperitoneal) and subcutaneous (inguinal) fat
pad weights in comparison with DIOres and chow-fed rats, the
latter being the group with the lowest fat mass (Fig. 1C).
Daily calorie intake was similar for chow-fed (80.4±3.0 kcal) and
DIOres (73.9±5.7 kcal) rats, but was significantly higher in DIOsens
rats (97.6±6.4 kcal, P<0.05) (Perez-Tilve et al., 2010). We further
assessed adipocytokine expression in retroperitoneal fat. Both
DIOres and DIOsens rats showed an increased expression of
inflammatory cytokines IL-6 and IL-1 compared with controls
(Fig. 1D). By contrast, expression of TNF and vascular endothelial
growth factor (VEGF) were only increased in DIOsens
retroperitoneal fat (Fig. 1D). No significant differences were
observed for monocyte chemotactic protein-1 (MCP-1) or
plasminogen activator inhibitor 1 (PAI-1).
Despite the bimodal distribution of body weight and fat mass in
HFD-fed compared with chow-fed rats, ad libitum fed blood
glucose levels were similar in all groups (Table 1). Fasted glucose
levels as well as insulin levels were significantly increased in
DIOsens rats, suggesting acquired early-stage glucose intolerance.
Nevertheless, fasted glucose levels were still in a normoglycemic
range, defined as a blood glucose concentration below 100 mg/dl
in humans (Table 1), and compared with the massive hyperglycemia
observed in diabetic Zucker (fa/fa) rats (Coimbra et al., 2000).
Circulating leptin and PAI-1 levels were significantly increased in
DIOsens rats, compared with chow controls (Table 1). A similar
trend was observed for circulating IL-1 but not for circulating
MCP-1 levels (Table 1). We were unable to detect circulating levels
of TNF or IL-6 with the multiplex immunoassay used for our
studies.
Increased severity of renal pathology in DIO rats
We next examined the impact of high body adiposity on the
development of renal pathology. Only marginal histopathological
changes were observed in chow-fed rats (Fig. 2A, Table 2). By
contrast, chronic HFD exposure induced pronounced
nephropathies in the corticomedullary region of DIOsens and
DIOres rats (Fig. 2B, Table 2), with significant correlation with both
increased body weight (P<0.001, R0.80; Fig. 2C) and combined
fat pad weights (P<0.001, R0.78; data not shown). Nephropathies
in DIO rats were characterized by glomerular damage, including
dilatation of glomerular blood vessels, exfoliation and shedding of
proximal tubular cells into the tubular lumen, proteinaceous cast
formation, thickened basement membrane, and interstitial
inflammation as evidenced by abundant interstitial monocytes (Fig.
2B, Table 2). Cellular damage was accompanied by ‘scarring’ of some
glomeruli (focal glomerular sclerosis) and tubules (tubulointerstitial
fibrosis), as well as by tubular regeneration (Fig. 2B, Table 2). Under
normal conditions, tubular regeneration serves to restore the loss
of damaged cells by a transient increase of cell proliferation but
without exceeding the normal single cell layer of a tubule. However,
in DIO rats, and especially in DIOsens rats, kidneys demonstrated
massive and sustained regenerative renal cell proliferation, resulting
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Fig. 1. Differing propensity towards HFD-induced body weight gain.
(A)Phenotypic appearance of chow-fed Wistar rats compared with HFD-fed
and partially DIO resistant (DIOres) or DIO sensitive (DIOsens) rats (Perez-Tilve
et al., 2010). (B,C)Body weights (B) and epididymal, retroperitoneal and
inguinal fat pad weights (C) after 11 months of exposure to chow or HFD
(DIOres, DIOsens). (D)Changes in adipocytokine expression in retroperitoneal
fat from chow-fed, DIOres and DIOsens rats after 11 months of diet exposure.
Values are given as mean ± s.e.m. Significant differences were analyzed by
one-way ANOVA and Bonferroni multiple comparison post tests and indicated
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in simple tubular hyperplasia, indicated by a broad increase of cell
number and multilayered tubules (Fig. 2B, Table 2). Sustained cell
proliferation was further visualized by immunohistochemical
staining of nuclear proliferating cell nuclear antigen (PCNA),
confirming a marked increase of proliferating cells within areas
presenting with the highest severity of pathological changes in
DIOres and especially DIOsens rats, when compared with controls
(Fig. 2D,E).
Lack of lipotoxicity in kidneys of DIO rats
Earlier reports have associated renal lipid accumulation with the
pathogenesis of chronic kidney disease in animal models of DIO
(Jiang et al., 2005; Kume et al., 2007; Hao et al., 2012) and diabetes
(Wang et al., 2005; Bobulescu et al., 2009). We therefore evaluated
a potential contribution of circulating free fatty acids (FFAs) and
renal triglyceride accumulation to the observed renal pathology in
DIO rats. However, fasting plasma triglyceride and FFA levels (Table
1) as well as kidney triglyceride content were similar in chow-fed
lean controls and DIO rats (Fig. 2F). The lack of renal lipid
accumulation was further corroborated by the absence of Oil-Red-
O-positive lipid droplets in kidneys of chow-fed and DIO rats (data
not shown). To estimate fatty acid flux into renal cells, we further
examined the expression of fatty acid transport proteins (FATPs),
a group of proteins that coordinate long-chain FFA uptake and
metabolism (supplementary material Fig. S1). The predominant
FATP expressed was FATP2, followed by FATP1 and FATP4;
FATP3 expression was lowest. FATP5 and FATP6 could not be
detected in rat kidney (data not shown). When comparing FATP
levels of chow-fed, DIOres and DIOsens rats, no changes in
expression levels could be observed for FATP1, 3 or 4
(supplementary material Fig. S1). Notably, FATP2 expression was
decreased in the kidneys of DIOsens rats, compared with chow-
fed controls (P<0.001).
Increased renal inflammation and STAT3 signaling in DIO rats
On the basis of the histological evidence of renal tissue
inflammation in DIO rats (Fig. 2B, Table 2) and the known role of
constitutive STAT3 activation in tumor promotion (Kuraishy et al.,
2011), we first examined the expression of known STAT3-activating
cytokines in the kidneys of lean and DIO rats. Expression of IL-6
was significantly increased in DIOsens rats compared with chow-
fed lean controls and DIOres rats (Fig. 3A). Moreover, IL-6 receptor
as well as IL-1 and TNF were slightly, but not significantly,
increased in DIOres rats and markedly increased in DIOsens rats,
compared with chow-fed controls (Fig. 3A-D). Similar to the
increase in circulating leptin in both DIOres and DIOsens rats
(Table 1), leptin receptor expression was increased in the kidneys
of both DIOres and DIOsens rats (Fig. 3E).
We next analyzed the expression of downstream transcriptional
targets of STAT3 signaling to evaluate STAT3 activation. Expression
levels of SOCS3 (Fig. 3F), MCP1/CCL2 (Fig. 3G) and PAI-1 (Fig.
3H) tended to be increased in DIOres rats, and were significantly
increased in DIOsens rats compared with chow-fed controls. In
order to directly assess the activity of STAT3, we performed
western blots from the renal cortex/outer medulla section for total
STAT3 (t-STAT3) and activated phospho-STAT3Tyr705 (p-STAT3).
In chow-fed rats, STAT3 phosphorylation was almost absent. By
contrast, STAT3 phosphorylation was increased in DIOres and
highest in DIOsens rats (Fig. 3I, left panel). Accordingly, ratios of
p-STAT3 to t-STAT3 increased with the degree of body adiposity
(DIOres: 13.7±5.5-fold, DIOsens: 25.7±11.0-fold, compared with
1.0±0.3-fold in chow-fed controls; Fig. 3I, right panel).
p-STAT3- and p-mTOR-positive renal preneoplasia in DIO rats
To elucidate whether the increase in STAT3 signaling correlates
with renal pathology, we applied immunohistochemistry to localize
the areas of activated STAT3 signaling. Only sporadic p-STAT3-
positive nuclei were observed in chow-fed rats or ‘healthy’ renal
tissues of DIO rats (data not shown). Accumulations of p-STAT3-
positive nuclei occurred predominantly in tubules that had an
atypical phenotype, i.e. in single atypical tubules (Fig. 4A) and early
atypical hyperplasia (Fig. 4C). These preneoplastic lesions are
characterized by pleomorphic nuclei with irregular shape, size or
cellular location and increased stratification of cells (Dietrich and
Swenberg, 1991; Hard et al., 1995). Hematoxylin and eosin (H&E)
staining of these lesions further revealed a basophilic staining of
the tubular cytoplasm (Fig. 4B) and increased numbers of
monocytes within the interstitium surrounding the lesions (Fig.
4B,D).
We found that preneoplastic lesions were almost absent in chow-
fed rats. By contrast, DIOsens rats had a significantly higher number
and incidence of atypical tubules (Fig. 4E). Notably, however, the
difference between the numbers of preneoplastic lesions in DIOres
and DIOsens kidneys was not statistically significant.
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Fasted glucose (mg/dl) 72.63±1.8 77.13±1.9 85.13±3.4b
Fed glucose (mg/dl) 99.63±2.4 99.75±3.7 104.5±3.0
Insulin (ng/ml) 1.72±0.30 1.62±0.21 2.94±0.34a,c
Triglycerides (mg/dl) 192.6±38.7 243.6±72.8 244.6±46.7
Free fatty acids (mM) 0.44±0.07 0.41±0.03 0.37±0.03
Plasma leptin (ng/ml) 3.06±0.23 4.46±0.43a 4.96±0.26b
Plasma PAI-1 (ng/ml) 1.28±0.17 1.96±0.26 2.92±0.44a
Plasma IL-1  (pg/ml) 9.36±2.98 11.90±3.44 26.33±12.12
Plasma MCP-1 (pg/ml) 106.40±18.60 109.21±21.35 100.75±10.29
Values are given as means ± s.e.m. Significant differences were analyzed using one-way ANOVA and Bonferroni’s multiple comparison post tests, and indicated by aP<0.05 and
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We next examined the activity of mTOR signaling in rat
kidneys via immunohistochemistry using antibodies directed
against mTOR phosphorylated at serine 2448 (Ser2448), or against
its downstream target, S6 ribosomal protein (S6RP)
phosphorylated at Ser235/236 (supplementary material Fig. S1).
Tubules with p-mTOR- and p-S6RP-positive cytoplasm were
primarily found in areas with increased cell proliferation (Fig. 4F,
supplementary material Fig. S2).
DISCUSSION
DIO has been recognized as an important risk factor for 
the development of kidney cancer (Calle et al., 2003; Renehan 
et al., 2008) [WCRF/AICR 2009 policy report
(http://www.dietandcancerreport.org/)]. However, causal
mechanisms still remain elusive. Accordingly, identification of the
hitherto unknown link between obesity and cancer has emerged
as a topic of major interest. Surprisingly, only a few predominantly
short-term studies have used rat models of DIO to investigate
adverse effects on renal physiology (Aguila and Mandarim-De-
Lacerda, 2003; Altunkaynak et al., 2008; Elmarakby and Imig, 2010;
Hao et al., 2012) and none of these focused on renal carcinogenesis.
Furthermore, none of these studies aimed to delineate adverse
direct effects of dietary fatty acids from indirect adverse effects
caused by the increased body adiposity.
As a model system, we used a common outbred Wistar rat strain.
Wistar rats, in contrast to inbred laboratory animals, have similar
but not identical genetic backgrounds, and are susceptible to
exogenous stimuli (such as a high-calorie diet). Accordingly, and
highly similar to human populations, our rats showed a broad
variation in body weight gain after 11 months of HFD exposure.
The morbidly obese phenotype of DIOsens rats could be explained
by increased calorie consumption. In addition, differential diet-
induced thermogenesis in DIOres and DIOsens rats could have
further contributed to the varying weight gain (Rothwell et al.,
1982). Overall, such differences in the propensity for DIO could
be due to both epigenetic variations and genetic predispositions,
especially because our rats were derived from closed colonies of
genetically variable composition. This strategy differs from that of
Levine et al., in which DIOres and DIOsens rats were derived from
consecutive backcrossing of rats with differing dispositions to body
weight gain (Levin et al., 1997). Although such backcrossing would
have resulted in a more severe phenotype of complete resistance
dmm.biologists.org630
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Fig. 2. Increased severity of renal pathology in DIO rats.
(A)Representative H&E-stained paraffin section of a kidney
from a chow-fed control animal without visible pathological
changes. (B)Pronounced nephropathy in DIOsens rats was
observed, including glomerulosclerosis (G), proteinaceous
casts (P), infiltration of monocytes (M), slightly basophilic
regenerating tubules with thickened basal membrane (white
arrow) and simple tubular hyperplasia (grey arrow).
(C)Spearman rank correlation of body weight with the severity
of overall renal pathology. (D)PCNA labeling indices (LI) of
chow-fed, DIOsens and DIOres rats. LI were determined for
proximal tubules within randomly chosen fields of the outer or
inner cortex. Within both regions at least 1000 positive and
negative nuclei were counted. LI were tested for significance
using one-way ANOVA and Bonferroni’s post tests for multiple
comparisons. **P<0.01. (E)Representative image of a PCNA-
stained kidney section from a DIOsens rat. Nuclear PCNA
staining represents cells after G1-S transition. (F)Absence of
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vs very high susceptibility to DIO, it could have also selected for
possible predisposition or resistance towards renal pathology,
which we wanted to avoid in our study.
By comparing lean rats on chow diet with groups of HFD-fed
DIOres and DIOsens rats, we could demonstrate that HFD-induced
obesity results in obesity-related nephropathy despite the lack of
frank hyperglycemia. The severity of these obesity-related
pathological alterations, such as glomerular and tubular
degeneration, glomerulosclerosis, interstitial fibrosis, and massive
regenerative cell proliferation, was increased in DIOres rats
compared with controls, and was most pronounced in DIOsens
rats (Fig. 2A-C, Table 2). Accordingly, we found a clear correlation
between the severity of the pathology, body weight and body
adiposity. However, when comparing the severities of pathological
alterations of DIOres and DIOsens rats, we did not detect any
significant differences. We therefore conclude that both increased
body fat and dietary fat overload contribute to the etiology of
obesity-induced non-neoplastic renal pathologies.
HFD feeding can result in elevated plasma levels of FFAs, which,
if not efficiently stored in adipose tissue in the form of triglycerides,
can be harmful to non-adipose tissues (Unger et al., 2010). For
instance, a recent study has demonstrated an altered balance
between renal lipogenesis and lipolysis in mice after 16 weeks of
HFD exposure, with subsequent accumulation of lipids in the
kidney, glomerulosclerosis and interstitial fibrosis (Kume et al.,
2007). Interestingly, DIO rats developed renal pathological changes
but the levels of plasma triglycerides, plasma FFA (Table 1) and
renal triglycerides (Fig. 2F) were unchanged compared with chow-
fed controls. Furthermore, similar expression levels of FATP1, 3
and 4 in chow-fed and DIO rats did not suggest increased FFA flux
into renal cells (supplementary material Fig. S1). In fact, decreased
expression of FATP2 in DIOsens rats might even protect from
excessive fatty acid influx into the kidney (supplementary material
Fig. S2). Altogether, our data suggest that alternative factors other
than lipotoxicity contribute to the etiology of DIO-mediated renal
pathology.
Hypertension as part of the metabolic syndrome has been
frequently related to end-stage renal disease. However, to date it
is still unknown whether hypertension is a cause or consequence
of renal injury (Tedla et al., 2011). Although dietary fat and
hypertension might directly or indirectly contribute to renal
damage, our data clearly point to a predominant role of body
adiposity in the development of renal pathologies in DIO rats.
Indeed, the elevated expression of proinflammatory adipocytokines
such as IL-6, IL-1 and TNF in the adipose tissue (Fig. 1D)
correlates with the renal inflammation in DIO rats, as revealed by
monocyte infiltration and significantly increased expression levels
of the inflammatory cytokines IL-6, IL-1, TNF and PAI-1, as well
as of the chemokine MCP-1 (Fig. 3A-H). Notably, we also found
increased expression levels of IL-6 receptor (Fig. 3D) and leptin-
receptor (Fig. 3E). The latter could further confirm a crosstalk
between adipose tissue and kidneys. In addition, the potential
condition of non-alcoholic steatohepatitis (NASH) in our DIO rat
model, and NASH-mediated hepatic secretion of (sub-threshold)
IL-6 levels or other inflammatory cytokines, could have further
contributed to a chronic inflammatory state and the development
of preneoplastic lesions. Nevertheless, although we found increased
expression of IL-6 in the kidneys and adipose tissue, we could not
detect circulating IL-6 in our rats.
Leptin (Baumann et al., 1996; Vaisse et al., 1996; Villanueva
and Myers, 2008) as well as various cytokines such as IL-6, TNF
and IL-1 (Yu et al., 2009; Grivennikov and Karin, 2011) have
been suggested as potent activators of STAT3 signaling in multiple
target organs. Upon activation of STAT3 by extracellular signals,
STAT3 is phosphorylated at Tyr705 by JAK kinases.
Phosphorylated STAT3 dimerizes and translocates to the nucleus,
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Nephropathy 0.0±0.3 2.0±0.4b 3.0±0.7c
Fibrous Bowman capsule 0.0±0.4 1.0±0.5 2.0±0.4
Glomerulosclerosis (focal) 0.0±0.0 1.0±0.5 2.0±0.7b
Glomerular basement membrane thickening 0.0±0.3 1.0±0.4 1.0±0.7
Glomerular microaneurisms 0.0±0.3 1.0±0.6 1.0±0.7
Apoptosis 0.0±0.0 1.0±0.6 1.0±0.7
Necrosis 0.0±0.0 0.0±0.3 0.0±0.7
Tubular regeneration 0.0±0.3 1.0±0.6 2.0±0.3a
Mitosis 0.0±0.0 0.5±0.5 1.0±0.4
Simple tubular hyperplasia 0.0±0.0 1.0±0.6 1.0±0.4a
Hypertrophic nuclei 0.0±0.0 1.0±0.6 1.0±0.3a
Protein casts 0.0±0.0 1.0±1.0 2.0±0.6b
Tubular dilatation 0.0±0.0 1.0±0.8a 1.0±0.7b
Calcium casts 0.0±0.0 0.0±0.4 1.0±0.3
Lipofuscin 0.0±0.0 0.0±0.6 0.0±0.4
Inflammation 0.0±0.3 1.0±0.6 2.0±0.3b
Fibrosis 0.0±0.0 1.0±0.5 1.0±0.3
Values are given as medians ± median absolute deviation (MAD). Significant differences were analyzed using a Kruskal-Wallis test followed by Dunn’s multiple comparison tests,















    
   D
M
M
where it orchestrates a multitude of signaling processes such as
those driving inflammation, cell survival, proliferation or cell
transformation (Yu et al., 2009; Grivennikov and Karin, 2011). In
consequence, STAT3 signaling has been associated with many
types of cancer (Al Zaid Siddiquee and Turkson, 2008), including
renal neoplasia (Horiguchi et al., 2002; Guo et al., 2009). Although
neither DIOsens nor DIOres rats presented with renal adenomas
or carcinomas, we observed an increase in the incidence of single
atypical tubules and atypical hyperplasia, i.e. early stages of renal
carcinogenesis. Such preneoplasia, although still reversible, have
the potential to develop to benign or malignant tumors (Dietrich
and Swenberg, 1991; Hard et al., 1995). Moreover, preneoplastic
lesions differed from ‘healthy’ tissue by agglomeration of p-
STAT3-positive nuclei (Fig. 4A-D), suggesting a persistent
activation of the STAT3 signaling pathway in these lesions. It
remains elusive whether persistent STAT3 activation is causally
related to the increased cell proliferation within these
preneoplastic tubules. Nevertheless, inflammation is now
recognized as an important hallmark of cancer development
(Hanahan and Weinberg, 2011). For instance, IL-6–STAT3
signaling has been shown to link obesity, inflammation and liver
cancer (Park et al., 2010).
Moreover, the observed upregulation of leptin receptor in
kidneys of DIO rats could have contributed to the development of
renal preneoplastic lesions in these rats. Leptin and increased leptin
receptor expression have been associated with various types of
cancer, including breast cancer (Jeong et al., 2011), colon cancer
(Stachowicz et al., 2010) and kidney cancer (Horiguchi et al., 2006).
Leptin has also been linked with mTOR activation (Maya-Monteiro
and Bozza, 2008), an important pathway that links nutrient
signaling to cell growth, proliferation and cancer (Dann et al., 2007).
Our data demonstrated mTOR phosphorylation as well as
downstream ribosomal protein S6 phosphorylation in areas of
increased renal epithelial cell proliferation, including preneoplastic
lesions (Fig. 4F, supplementary material Fig. S2). Such increased
cell proliferation (independent from its initial stimuli) is known to
further propagate the fixation of spontaneous mutations and
progression of preneoplastic lesions into solid tumors (Cohen and
Ellwein, 1991; Dietrich and Swenberg, 1991).
In conclusion, our data suggest that prolonged HFD exposure
induces a plethora of potential STAT3-activating signals in DIO
rat kidneys, whereby severe obesity exacerbates the onset and
progression of nephropathy and preneoplasia. Future studies should
aim to further assess the causal role of locally produced cytokines
or even adipocyte-derived hormones, including leptin, in the
kidney’s inflammatory microenvironment that is associated with
the development of renal preneoplasia.
METHODS
Animals
Male Wistar rats (Harlan, IN; n32, 250-350 g, age 2 months) were
allowed ad libitum access to a HFD (40% calories from butter fat,
46% from corn starch; Research Diets, NJ). After 11 months of HFD
exposure, groups of rats at each extreme – based on their body
weight (BW) – were selected and defined as DIO sensitive
(DIOsens; BW range: 947-1247 g, n7) and partially DIO resistant
(DIOres; BW range: 587-707 g, n8) (Perez-Tilve et al., 2010). Both
sub-populations were compared with rats (BW range: 427-508 g,
n8) exposed to standard chow diet (LM-485; 17% calories from
fat, 58% from carbohydrates; Teklad Harlan, IN). All rats were
single-housed, and daily calorie consumption was assessed for 5
days before terminating the experiment. Rats were sacrificed by
decapitation, and trunk blood was collected. Inguinal,
retroperitoneal and epididymal fat depots were excised, weighed
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Fig. 3. Increased renal inflammation and STAT3
signaling in DIO rats. (A-H)Relative gene expression
levels normalized to the geometric average of the
respective housekeeping gene hypoxanthine
guanine phosphoribosyl transferase 1 (HPRT1).
(A)Interleukin 6 (IL-6), (B) interleukin 1 (IL-1), (C)
tumor necrosis factor- (TNF), (D) interleukin 6
receptor (IL6-R), (E) leptin receptor (Lep-R), (F)
suppressor of cytokine signaling 3 (SOCS3), (G)
monocyte chemotactic protein-1 (MCP-1), (H)
plasminogen activator inhibitor-1 (PAI-1).
(I)Representative western blot (n3-4) and
densitometric analysis (n7-8) of phosphorylated
STAT3 (p-STAT3) and total STAT (t-STAT3). The ratio of
p-STAT3 to t-STAT3 from DIOres and DIOsens rats was
normalized to the ratio derived from chow-fed
controls (defined as onefold change). All values are
given as means ± s.e.m. Significant differences were
analyzed by using one-way ANOVA and Bonferroni
multiple comparison post tests and indicated as
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and frozen on dry ice. Kidneys were excised, cross-sectioned and
either frozen on dry ice or fixed in 10% buffered formalin before
paraffin embedding. All animal studies were approved by the
Institutional Animal Care and Use Committees at the University
of Cincinnati Office, in accordance with the NIH guide for the care
and use of laboratory animals.
Blood parameters
At 2 weeks prior to sacrifice, we collected plasma from tail blood
of overnight fasted rats. Circulating non-esterified fatty acid,
triglyceride and cholesterol levels were determined by enzymatic
assays (NEFA, Wako, Germany; Infinity triglyceride and Infinity
cholesterol, Thermo Electron, FL). Circulating insulin and
adipokine levels were measured by using multiplex panels from
LINCOplex (St Charles, MO). All measurements were performed
in duplicate according to the manufacturers’ instructions. Detection
limits for adipocytokines were: leptin 9.7 pg/ml, IL-1 1.2 pg/ml,
IL-6 8.8 pg/ml, TNF, 3.2 pg/ml, MCP-1 25.8 pg/ml, PAI-1 (active)
31.6 pg/ml, PAI-1 (total) 30.7 pg/ml and insulin 52.5 pg/ml. Fed
and fasted blood glucose levels were measured directly from tail
blood by using glucometers (TheraSense Freestyle).
Renal pathology
H&E-stained paraffin sections were randomized for blinded
histopathological evaluation, and non-neoplastic pathology was
ranked as absent (0), mild (1), moderate (2), pronounced (3) or
severe (4). Preneoplastic lesions were characterized as atypical
tubules (characterized by tubules of normal size but altered cell
types including multilayered cells with irregular nuclei and/or
cytoplasm and frequent mitotic figures) and atypical hyperplasia
(characterized by the accumulation of atypical tubules, but without
compression or infiltration of surrounding tissue) (Dietrich and
Swenberg, 1991). Total numbers of preneoplastic lesions were
counted and incidences per animal determined.
Renal triglyceride quantification
Kidney triglycerides were extracted from 50 mg frozen
corticomedullary kidney sections using a chloroform/methanol
(2:1) extraction procedure adapted from previous studies (Frayn
and Maycock, 1980; Nogueiras et al., 2007). After evaporation of
the organic solvent, triglyceride contents were determined by an
enzymatic method (Infinity Triglycerides Reagent, Thermo Fisher
Scientific, VA), according to the manufacturer’s instructions. Rat
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Fig. 4. p-STAT3- and p-mTOR-positive renal preneoplasia in
DIO rats. (A,B)Preneoplastic tubules in DIO rats. (A)Nuclear
phospho-STAT3 (p-STAT3) staining and (B) H&E of a
preneoplastic tubule, indicated by pleomorphic cells and nuclei
and their proliferation beyond a single cell layer (black arrow).
(C,D)Atypical hyperplasia in DIO rats with p-STAT3-positive
nuclei, including some p-STAT3-positive giant nuclei (C) or
basophilic cytoplasm of an H&E-stained section, indicating a
high replicative activity of the lesion (D). (E)Total number and
incidences of atypical tubules (AT) and atypical hyperplasia (AH)
in chow-fed controls, DIOres rats and DIOsens rats. Significant
differences were analyzed using one-way ANOVA and
Bonferroni multiple comparison post tests and indicated as
*P<0.05, **P<0.01 and ***P<0.001 vs chow controls. (F)Simple















    
   D
M
M
kidneys were further evaluated for lipid droplet accumulation using
Oil Red O staining. Cryosections were cut and stained by the
Pathology Research Core facility of the Cincinnati Children’s
Hospital Medical Center (Cincinnati, OH).
Real-time PCR
RNA was isolated from retroperitoneal fat and kidneys using
RNeasy Lipid Tissue mini kits, and RNeasy mini kits, respectively
(Qiagen, CA). RNA was transcribed into cDNA by using
Superscript III reverse transcriptase, according to the
manufacturer’s instructions (Invitrogen, CA). Quantitative real-
time PCR (Q-PCR) reactions were performed in an ABI Prism
7900HT Sequence Detection System by using specific TaqMan
probe sets listed in supplementary material Table S1. Q-PCR
reactions for the detection of fatty acid transport proteins were
performed in a MyiQ Real-Time PCR detection system (Bio-Rad,
CA), using iQ SYBR Green Supermix (Bio-Rad) and specific
primer pairs listed in supplementary material Table S2. Relative
expression levels were normalized to the housekeeping gene
hypoxanthine guanine phosphoribosyl transferase 1 (HPRT1);
expression changes were evaluated using the delta-delta Ct (Ct)
method.
Western blotting
Total protein was extracted from the cortico/medullary region of
the kidneys, and phospho-STAT3Tyr705 (p-STAT3; Cell Signaling
Technology, MA, #9131) and total STAT3 (Cell Signaling
Technology, #9132) were detected via western blot analysis.
Detections were carried out using horseradish-peroxidase-linked
secondary antibody (Cell Signaling Technology, #7074) followed
by enhanced chemiluminescence detection (Perkin Elmer, MA,
#NEL105001EA). Densitometric analysis (using ImageJ software,
http://rsb.info.nih.gov/ij) was applied to compare normalized ratios
of p-STAT3 vs t-STAT3, with the ratio of chow-fed controls being
defined as 1.
Immunohistochemistry
p-STAT3Tyr705 and p-mTORSer2448 staining on renal paraffin sections
was done using primary antibodies for p-STAT3 (Cell Signaling
Technology, #9145) and p-mTOR (Cell Signaling Technology,
#2976), according to the manufacturer’s protocols. Antigen-
antibody complexes were visualized using the Super Sensitive One
Step Polymer HRP detection system (Biogenex, CA) with DAB as
a chromogen. Immunohistochemical staining of phospho-S6
ribosomal proteinSer235/236 (p-RPS6) and proliferating nuclear
antigen (PCNA) was done as previously described (Stemmer et al.,
2007; Stemmer et al., 2009). All the sections were counterstained
with Meyer’s hematoxylin for 3 minutes.
Cell proliferation analysis
PCNA-positive S-phase nuclei, indicating cell proliferation, were
quantified on randomized paraffin sections. A total of 20
microscopic fields (10 ocular, 40 objective) were randomly
chosen within the renal corticomedullary area. At least 1000
proximal tubules were counted per section, distinguishing between
positive PCNA-stained and negative (hematoxylin-counterstained)
nuclei. Nuclear labeling indices (LI) were calculated as positive
nuclei/total number of nuclei counted.
Statistics
Significant differences between chow-fed, DIOres and DIOsens
animals were evaluated by one-way ANOVA and post-hoc
Bonferroni multiple comparison tests. Ranked non-neoplastic
pathology data were analyzed by Kruskal-Wallis tests. All analyses
were performed by using GraphPad Prism 5.0 (GraphPad, CA).
Results were considered statistically significant when P<0.05, with
significance levels indicated as *P<0.05, **P<0.01 and ***P<0.001.
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TRANSLATIONAL IMPACT
Clinical issue
The ongoing global obesity epidemic poses an urgent health threat owing to a
concomitant rise in comorbidities such as kidney cancer. In their 2009 policy
report, the World Cancer Research Fund/American Institute for Cancer
Research (WCRF/AICR) attributed 24% of all kidney cancer cases to obesity.
Although the exact mechanisms underlying this increased risk remain elusive,
current research suggests that obesity-associated increases in the levels of
inflammatory (adipo)cytokines and direct lipotoxic effects from dietary fatty
acids are potential culprits. Both of these factors might induce obesity-related
nephropathy and an inflammatory and procarcinogenic kidney
microenvironment that could promote the manifestation of preneoplasia, i.e.
early-stage kidney cancer. 
Results
By comparing lean, chow-fed rats with groups of non-diabetic, high-fat-diet
(HFD)-fed rats that were either sensitive or partially resistant to diet-induced
obesity (DIO), the authors demonstrate a clear correlation between high body
adiposity and the severity of renal pathology. Animals prone to DIO also
showed the highest incidence of preneoplasia, i.e. early-stage kidney cancer.
The similar levels of plasma triglyceride, plasma free fatty acid and renal
triglyceride found in both chow-fed and HFD-fed rats suggest that lipotoxicity
is not a crucial contributor to the renal pathology. By contrast, the authors
show that the kidneys of DIO rats exhibit an inflammatory and
procarcinogenic microenvironment, characterized by monocyte infiltration,
cytokine expression, elevated circulating leptin levels and increased kidney
leptin receptor expression. Increased phosphorylation of STAT3 and
mammalian target of rapamycin (mTOR) primarily in tubules with
preneoplastic phenotypes suggests a major role for these tumor-promoting
pathways in obesity-induced kidney carcinogenesis.
Implications and future directions
This detailed morphological analysis of obesity-induced renal pathology in
outbred Wistar rats with differing propensities for DIO revealed a close
similarity to renal disease in obese humans. Importantly, renal cell carcinomas
in rats have been demonstrated to closely resemble renal cancer in humans.
Thus, Wistar rats are a valuable animal model with which to unravel the causal
link between obesity and kidney cancer. Future research should aim to
delineate the individual roles of renal cytokines and STAT3 and/or mTOR
activation in the etiology of obesity-induced kidney cancer, and their potential
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